These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38865276)

  • 1. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
    Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
    Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
    Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance.
    Andronikou C; Rottenberg S
    Trends Mol Med; 2021 Jul; 27(7):630-642. PubMed ID: 34030964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
    Zhang H; Lin X; Zha S
    Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification.
    Rouleau-Turcotte É; Pascal JM
    J Biol Chem; 2023 Dec; 299(12):105397. PubMed ID: 37898399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
    Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
    Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.
    Longarini EJ; Dauben H; Locatelli C; Wondisford AR; Smith R; Muench C; Kolvenbach A; Lynskey ML; Pope A; Bonfiglio JJ; Jurado EP; Fajka-Boja R; Colby T; Schuller M; Ahel I; Timinszky G; O'Sullivan RJ; Huet S; Matic I
    Mol Cell; 2023 May; 83(10):1743-1760.e11. PubMed ID: 37116497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
    Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
    Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication.
    Zhang H; Zha S
    DNA Repair (Amst); 2024 Aug; 140():103690. PubMed ID: 38823186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
    Jain PG; Patel BD
    Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.
    Mashimo M; Kita M; Nobeyama A; Nomura A; Fujii T
    Genes Cells; 2022 Apr; 27(4):305-312. PubMed ID: 35124853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3.
    Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND
    Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Yamaguchi H; Du Y; Nakai K; Ding M; Chang SS; Hsu JL; Yao J; Wei Y; Nie L; Jiao S; Chang WC; Chen CH; Yu Y; Hortobagyi GN; Hung MC
    Oncogene; 2018 Jan; 37(2):208-217. PubMed ID: 28925391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP trapping is governed by the PARP inhibitor dissociation rate constant.
    Gopal AA; Fernandez B; Delano J; Weissleder R; Dubach JM
    Cell Chem Biol; 2024 Jul; 31(7):1373-1382.e10. PubMed ID: 38262416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
    Matkarimov BT; Zharkov DO; Saparbaev MK
    Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
    Zhen Y; Zhang Y; Yu Y
    Cell Rep; 2017 Nov; 21(8):2326-2337. PubMed ID: 29166620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.